Shuangyan Cao

1.0k citations

48 papers · 550 indexed · h-index 15

Rheumatology top 5%
- Spondyloarthritis Studies and Treatments 36
- Rheumatoid Arthritis Research and Therapies 22
- Systemic Lupus Erythematosus Research 7
Hematology top 10%
- Autoimmune and Inflammatory Disorders Research 8
Immunology
- Psoriasis: Treatment and Pathogenesis 13
Orthopedics and Sports Medicine top 10%
- Bone and Joint Diseases 5
Nephrology top 10%
Molecular Biology
- Inflammasome and immune disorders 4
Psychiatry and Mental health
- Fibromyalgia and Chronic Fatigue Syndrome Research 3

Co-authors: Jieruo Gu Qiujing Wei Zetao Liao Zhiming Lin Liudan Tu Qing Lv Qiuxia Li Li T
Cited by: Rheumatology Hematology Immunology
Journals: PLoS ONE (3 papers)Frontiers in Immunology (3 papers)Annals of the Rheumatic Diseases (3 papers)
Partner nations: China United Kingdom Mongolia

In The Last Decade

Shuangyan Cao

44 papers receiving 541 citations

Peers

Countries citing papers authored by Shuangyan Cao

Since Specialization

Citations

This map shows the geographic impact of Shuangyan Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuangyan Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuangyan Cao more than expected).

Fields of papers citing papers by Shuangyan Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuangyan Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuangyan Cao. The network helps show where Shuangyan Cao may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shuangyan Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shuangyan Cao Line = papers co-authored together Shuangyan Cao links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Evaluating the performance of large language models in health education for patients with ankylosing spondylitis/spondyloarthritis: a cross-sectional, single-blind study in China BMJ Open ·Yong Ren,Yuening Kang,Shuangyan Cao,Fanxuan Meng,Jingyu Zhang,Ruyi Liao,Xiaomin Li,Yuling Chen,Ya Wen,Jiayun Wu,Wenqi Xia,Liling Xu,Shenghui Wen,Huifen Liu,Yuanqing Li,Jieruo Gu,Qing Lv	2025	3
2	In‐cell Catalysis by Tethered Organo−Osmium Complexes Generates Selectivity for Breast Cancer Cells ChemBioChem ·James P. C. Coverdale,Rebecca A. Bedford,Oliver W. L. Carter,Shuangyan Cao,Martin Wills,Peter J. Sadler	2024	6
3	Etanercept/celecoxib on improving MRI inflammation of active ankylosing spondylitis: A multicenter, open-label, randomized clinical trial Frontiers in Immunology ·Liudan Tu,Minjing Zhao,Xiaohong Wang,Qingcong Kong,Zena Chen,Qiujing Wei,Qiuxia Li,Qing-Hong Yu,Zhizhong Ye,Shuangyan Cao,Zhimin Lin,Zetao Liao,Qing Lv,Jun Qi,Ou Jin,Yunfeng Pan,Jieruo Gu	2022	5
4	Age-Specific Imbalance of Circulating Tfh Cell Subsets and Its Association With Gout-Targeted Kidney Impairment Frontiers in Immunology ·Yefei Huang,Xinyu Wu,Lian Gui,Yutong Jiang,Liudan Tu,Xiaomin Li,Boxiong Jiang,Yina Wang,Xuqi Zheng,Qiujing Wei,Qiuxia Li,Jiayong Ou,Zena Chen,Ya Xie,Zhiming Lin,Zetao Liao,Linkai Fang,Minli Qiu,Shuangyan Cao,Jieruo Gu	2021	5
5	Serum Metabolomics Signatures Associated With Ankylosing Spondylitis and TNF Inhibitor Therapy Frontiers in Immunology ·Jiayong Ou,Min Xiao,Yefei Huang,Liudan Tu,Zena Chen,Shuangyan Cao,Qiujing Wei,Jieruo Gu	2021	23
6	Comorbidities and factors influencing frequent gout attacks in patients with gout: a cross-sectional study Clinical Rheumatology ·Jing Liang,Yutong Jiang,Yefei Huang,Yulan Huang,Feng Liu,Yanli Zhang,Mingcan Yang,Jialing Wu,Min Xiao,Shuangyan Cao,Jieruo Gu	2021	16
7	TNF-α inhibitor therapy can improve the immune imbalance of CD4+ T cells and negative regulatory cells but not CD8+ T cells in ankylosing spondylitis Arthritis Research & Therapy ·Mingcan Yang,Qing Lv,Qiujing Wei,Yutong Jiang,Jun Qi,Min Xiao,Linkai Fang,Ya Xie,Shuangyan Cao,Zhiming Lin,Yanli Zhang,Liudan Tu,Minjing Zhao,Yunfeng Pan,Ou Jin,Jieruo Gu	2020	26
8	Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated With Adalimumab in China Frontiers in Public Health ·Liudan Tu,Ya Xie,Zetao Liao,Yutong Jiang,Qing Lv,Shuangyan Cao,Qiujing Wei,Jieruo Gu	2020	6
9	Spondyloarthritis Patients Suffer Increased Risk of Renal Complications Compared With General Population: A Retrospective Observational Study Frontiers in Pharmacology ·Min Xiao,Qing Lv,Yanli Zhang,Liudan Tu,Mingcan Yang,Zhiming Lin,Zetao Liao,Yutong Jiang,Xuqi Zheng,Xiaomin Li,Qiujing Wei,Shuangyan Cao,Jieruo Gu	2019	3
10	Complex Segregation Analysis Provides Evidence for Autosomal Dominant Transmission in the Chinese Han Families with Ankylosing Spondylitis BioMed Research International ·Yutong Jiang,Qing Lv,Shaoqi Rao,Zetao Liao,Ping Zhang,Mingcan Yang,Qiuxia Li,Shuangyan Cao,Zhiming Lin,Jieruo Gu	2017	1
11	Prevalence of psychological disorders, sleep disturbance and stressful life events and their relationships with disease parameters in Chinese patients with ankylosing spondylitis Clinical Rheumatology ·Yutong Jiang,Mingcan Yang,Qing Lv,Jun Qi,Zhiming Lin,Zetao Liao,Yanli Zhang,Husheng Wu,Hui Song,Feng Zhan,Shengyun Liu,Guanmin Gao,Shaoxian Hu,Yinong Li,Lingxun Shen,Anbing Huang,Qiujing Wei,Shuangyan Cao,Jieruo Gu	2017	29
12	Prevalence of comorbidities and evaluation of screening in Chinese patients with spondyloarthritis Clinical Rheumatology ·Yutong Jiang,Ping Zhang,Liudan Tu,Qing Lv,Jun Qi,Zhiming Lin,Zetao Liao,Shuangyan Cao,Jieruo Gu	2017	7
13	Kunxian capsules in the treatment of patients with ankylosing spondylitis: a randomized placebo-controlled clinical trial Trials ·Qiuxia Li,Li Li,Liqi Bi,Changhong Xiao,Zhiming Lin,Shuangyan Cao,Zetao Liao,Jieruo Gu	2016	17
14	A Genome-Wide SNP Linkage Analysis Suggests a Susceptibility Locus on 6p21 for Ankylosing Spondylitis and Inflammatory Back Pain Trait PLoS ONE ·Yanli Zhang,Zetao Liao,Qiujing Wei,Yunfeng Pan,Xinwei Wang,Shuangyan Cao,Zishi Guo,Yuqiong Wu,Ju Rong,Ou Jin,Manlong Xu,Zhiming Lin,Jieruo Gu	2016	2
15	A Rare Co-Segregation-Mutation in the Insulin Receptor Substrate 1 Gene in One Chinese Family with Ankylosing Spondylitis PLoS ONE ·Rong Ju,Qiuxia Li,Ping Zhang,Xinyu Wu,Jinxian Huang,Chao Li,Zetao Liao,Yingying Xie,Qing Lv,Qiujing Wei,Li T,Jianlin Huang,Shuangyan Cao,Yan Shen,Jieruo Gu	2015	7
16	Higher Percentage of CD3+CD154+ T Lymphocytes Predicts Efficacy of TNF-α Inhibitors in Active Axial SpA Patients Inflammation ·Zhiming Lin,Qu Lin,Zetao Liao,Qiuxia Li,Fucheng Zhang,Qiujing Wei,Shuangyan Cao,Jieruo Gu	2014	2
17	MiR-27a Targets sFRP1 in hFOB Cells to Regulate Proliferation, Apoptosis and Differentiation PLoS ONE ·Donggeng Guo,Qiuxia Li,Qing Lv,Qiujing Wei,Shuangyan Cao,Jieruo Gu	2014	70
18	ERAP1Is Associated with Ankylosing Spondylitis in Han Chinese The Journal of Rheumatology ·Chao Li,Zhiming Lin,Yingying Xie,Zishi Guo,Jinxian Huang,Qiujing Wei,Qiu Xia Li,Xinwei Wang,Shuangyan Cao,Zetao Liao,Manlong Xu,Yan Shen,Jieruo Gu	2010	28
19	Abnormal high-expression of CD154 on T lymphocytes of ankylosing spondylitis patients is down-regulated by etanercept treatment Rheumatology International ·Qu Lin,Zhiming Lin,Jieruo Gu,Feng Huang,Li T,Qiujing Wei,Zetao Liao,Shuangyan Cao,Yingjuan Jiang,Jinxian Huang	2009	11
20	Mutations in the LDL receptor gene in four Chinese homozygous familial hypercholesterolemia phenotype patients Nutrition Metabolism and Cardiovascular Diseases ·Liang Wang,Jie Lin,S. Liu,Shuangyan Cao,J. Liu,Yong Qiang,Yilong Yang,Bingqun Wu,Xiao-Dong Pan,Liang Du,Chan Wu,Yanwen Qin,B. Chen	2008	20

About Shuangyan Cao

Shuangyan Cao is a scholar working on Rheumatology, Hematology and Immunology, having authored 48 papers that have together received 550 indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (36 papers), Rheumatoid Arthritis Research and Therapies (22 papers), Psoriasis: Treatment and Pathogenesis (13 papers), Autoimmune and Inflammatory Disorders Research (8 papers), Systemic Lupus Erythematosus Research (7 papers), Bone and Joint Diseases (5 papers), Inflammasome and immune disorders (4 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers). The work is most often cited by research in Rheumatology (327 citations), Hematology (105 citations) and Immunology (161 citations). Shuangyan Cao has collaborated with scholars based in China, United Kingdom and Mongolia. Frequent co-authors include Jieruo Gu, Qiujing Wei, Zetao Liao, Zhiming Lin, Liudan Tu, Qing Lv, Qiuxia Li, Qing Lv, Li T and Qiuxia Li. Their work appears in journals such as PLoS ONE, Frontiers in Immunology and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact